ID   2-2 [Mouse hybridoma against human IL26]
AC   CVCL_C7I5
DR   Wikidata; Q123030233
RX   Patent=JP7061750;
RX   PubMed=31397631;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE P-02580.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NPH9; Human IL26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
RX   Patent=JP7061750;
RA   Hatano R., Morimoto C., Itoh T., Ohnuma K.;
RT   "Anti-human IL-26 antibody.";
RL   Patent number JP7061750, 02-May-2022.
//
RX   PubMed=31397631; DOI=10.1080/19420862.2019.1654305;
RA   Hatano R., Itoh T., Otsuka H., Okamoto S., Komiya E., Iwata S.,
RA   Aune T.M., Dang N.H., Kuwahara-Arai K., Ohnuma K., Morimoto C.;
RT   "Characterization of novel anti-IL-26 neutralizing monoclonal
RT   antibodies for the treatment of inflammatory diseases including
RT   psoriasis.";
RL   MAbs 11:1428-1442(2019).
//